NPPA Revises Drug Prices | 16 Oct 2024

Source: PIB

Recently, the National Pharmaceutical Pricing Authority (NPPA) has approved a 50% increase in the ceiling prices of eleven scheduled formulations of eight drugs under the Drugs Prices Control Order, 2013.

These drugs are indicated for the treatment of conditions such as Asthma, Glaucoma, Thalassemia, Tuberculosis, and mental health disorders.
National Pharmaceutical Pricing Authority (NPPA):
- NPPA was formed in 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilisers.
- An independent regulator that sets drug prices and ensures their availability and accessibility.
- It derives authority from the Drugs Prices Control Order, 2013, and the Drugs and Cosmetics Act, 1940.
- NPPA administers ‘Pharma Sahi Daam’ and ‘Pharma Jan Samadhan’ platforms for information on medicine prices and registering public grievances.
  - The Integrated Pharmaceutical Database Management System 2.0 (IPDMS) is being implemented for online information collection from Pharma manufacturers.